Sign in

CIK 0001374328 · Non-accelerated filer<br>Smaller reporting company

FITLIFE BRANDS, INC.

Sign in to watch
Ticker
FTLF
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
NV
Entity type
operating
Phone
402-884-1894
Business address
5214 S. 136TH STREET, OMAHA, NE, 68137
Former names
BOND LABORATORIES, INC.
  1. 4 Grant or award Director acquired 266 shares (grant or award)
  2. 4 Conversion CHIEF EXECUTIVE OFFICER acquired 123,222 shares (conversion)
  3. 4 Grant or award Director acquired 375 shares (grant or award)
  4. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 1,000 shares at $8.73 ($8,730)
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 40,508 shares at $9.75 ($394,953)
  7. 4/A Grant or award Director acquired 406 shares (grant or award)
  8. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 52,000 shares at $8.50 ($442,000)
  9. 4 Grant or award Director acquired 406 shares (grant or award)
  10. 4 Grant or award Director acquired 6,697 shares (grant or award)
  11. 4 Grant or award Director acquired 13,393 shares (grant or award)
  12. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 12,000 shares at $0.50 ($6,000)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 224,455 shares at $0.50 ($112,228)
  15. 4 Grant or award Director acquired 8,721 shares (grant or award)
  16. 4 Grant or award Director acquired 13,082 shares (grant or award)
  17. 4 Grant or award Director acquired 13,082 shares (grant or award)
  18. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 1,110,999 shares at an average $0.49 ($546,317)
  19. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 49,400 shares at an average $0.35 ($17,327)
  20. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 27,169 shares at an average $0.40 ($10,894)

Page 3 of 9 · 175 filings